Mayo Clinic
Researchers are collecting and storing blood, stool, and urine samples and medical information to better understand Inflammatory Bowel Disease (IBD) to improve disease outcome.
Subjects will be sent a letter detailing the proposed biobank and soliciting enrollment. Following the informed consent process, subjects will provide a blood sample (50 ml), urine sample (50 ml), and stool. The blood and urine samples will either be collected at the one of the Mayo Clinic outpatient laboratories or by a mail-out kit. Subjects will be asked to complete a questionnaire and 24-hour food recall questionnaire (completed online).
Inclusion Criteria: * Patients diagnosed with inflammatory bowel disease (IBD) who are between the ages of 18 and 85 at time of study enrollment. * The diagnosis of IBD will be based on the standard IBD criteria including biochemical and colonoscopy screening. * Women with inflammatory bowel disease of childbearing potential and pregnant women will be offered enrollment because there is no risk to an unborn child in this investigation. * Patients between the ages of 18 and 85 without history of IBD or colon cancer. Exclusion Criteria: * Patients with known liver disease. * Patients unable t…
50 ml will be collected
50 ml will be collected
Three 25 ml tubes will be collected
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.